PharmiWeb.com - Global Pharma News & Resources
23-Oct-2018

US Psoriasis Market and Competitive Landscape Report 2018 with Sales Forecasts to 2023 - ResearchAndMarkets.com

The "US Psoriasis Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

US Psoriasis Market and Competitive Landscape - 2018, provides comprehensive insights into Psoriasis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Psoriasis market size and drug sales. This research also provides insights into Psoriasis epidemiology and late stage pipeline.

The research is classified into following sections - Psoriasis overview with definitions, symptoms, etiology, diagnosis, treatment options; Psoriasis pipeline insights covering late stage clinical trials pipeline; Psoriasis prevalence trends by countries; Psoriasis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

  • Psoriasis pipeline: Find out the drugs in clinical trials for Psoriasis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Psoriasis epidemiology: Find out the prevalence of Psoriasis in US; prevalence forecast to 2023
  • Psoriasis products: Identify key products marketed and prescribed for Psoriasis by brand name, by molecule, by company, by branded / generic, in US
  • Psoriasis market size: Find out the market size for Psoriasis drugs in US; Find out how the market advanced from 2014
  • Psoriasis drug sales: Find out the sales of Psoriasis drugs in US
  • Psoriasis drugs sales forecast: Sales forecast for Psoriasis drugs to 2023 in US
  • Psoriasis market share analysis: Find out the market shares of Psoriasis drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/wbk79n/us_psoriasis?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181023005974/en/

Editor Details

Last Updated: 23-Oct-2018